Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Anterogen Co. Ltd.
DescriptionAllogeneic mesenchymal stem cells
Molecular Target
Mechanism of Action 
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPhase I
Standard IndicationBlistering disorder
Indication DetailsTreat dystrophic epidermolysis bullosa
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today